SCHEDULE: Vanguard Reports 0% Eastman Chemical Stake Post-Realignment
Beneficial Ownership Amendment
The Vanguard Group has filed an amended Schedule 13G for Eastman Chemical Co, reporting 0% beneficial ownership due to an internal organizational realignment.
Summary
- The Vanguard Group filed an Amendment No. 17 to Schedule 13G for Eastman Chemical Co, indicating 0% beneficial ownership of common stock.
- This change stems from an internal realignment at The Vanguard Group, Inc. on January 12, 2026.
- Following the realignment, certain subsidiaries or business divisions of Vanguard will now report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538.
- The Vanguard Group, Inc. itself no longer has, or is deemed to have, beneficial ownership over securities now reported by its subsidiaries and/or business divisions.
- The filing confirms that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Eastman Chemical Co.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. It is a procedural update regarding beneficial ownership reporting by a major institutional investor, not an indicator of performance or strategic shift for Eastman Chemical Co.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that large institutional investors like The Vanguard Group periodically undergo internal reorganizations or refine their reporting structures. This particular filing reflects a procedural change in how Vanguard's beneficial ownership is aggregated and reported, rather than a strategic divestment from Eastman Chemical Co. Such disaggregated reporting can provide more granular insight into specific fund or subsidiary holdings, aligning with regulatory guidance.
Stakeholder Impact
- Shareholders of Eastman Chemical Co: Minimal direct impact, as the underlying shares are still held within the Vanguard family of funds, just reported differently.
- Investment professionals: Provides clarity on Vanguard's internal reporting structure for beneficial ownership.
Key Dates
| Date | Description |
|---|---|
| 1998-01-12 | Date of SEC Release No. 34-39538, which allows for disaggregated reporting of beneficial ownership. |
| 2026-01-12 | Date of internal realignment at The Vanguard Group, Inc. |
| 2026-03-13 | Date of event which requires the filing of this statement. |
| 2026-03-26 | Date the Schedule 13G/A was signed and filed. |
Keywords
Vanguard Group, Eastman Chemical Co, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Investor, Asset Management, Corporate Realignment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.